Xlumena Funding Rounds

Add Funding

Date	Round	Amount	Investors
Dec 03, 2013	Series C	$ 25,000,000	Charter Life Sciences Third Point Ventures Prism Venture Management Aperture Venture Partners Ascent Biomedical Ventures
Oct 04, 2013	Debt Financing	$ 6,000,001
Aug 22, 2012	Debt Financing	$ 5,922,681
Apr 29, 2011	Series B	$ 7,000,000	Western Technology Investment Charter Life Sciences Ascent Biomedical Ventures Prism Venture Management Aperture Venture Partners
May 17, 2010	Series A	$ 2,999,999

Return to Xlumena »